Navigation Links
Study Reveals Multiple Root Causes for Drug Shortages
Date:6/12/2013

mphasis on building strong relationships with regulatory authorities. Respondents from companies that avoided shortages also cited the importance of fostering communication links between the companies and the regulators as an important success factor.

ISPE plans to further analyze the survey findings, and present and publish additional reports in the future. ISPE is also concurrently conducting a study on clinical trial packaging to help industry better understand how packaging and labeling of clinical trial medicines is viewed from the perspective of patients. This study is expected to be released in November 2013 during the ISPE Annual Meeting.

To download the Report on the ISPE Drug Shortages Survey please visit www.ISPE.org/DrugShortages/2013JuneReport.

About the ISPE Drug Shortages Survey Report
ISPE deployed the Drug Shortages Survey to its global database of members and non-members for five weeks beginning February 20, 2013. The organization also worked with several reporters and publications covering the pharmaceutical industry to ensure maximum outreach and participation by industry participants with direct knowledge of actual drug shortages and shortages that had been narrowly avoided. In addition to seeking respondents to answer the survey items based on their individual experiences and opinions, ISPE also encouraged companies to compile an enterprise-level response and to designate a member of their staff to enter the information into the electronic survey system. In this way, duplication of data was minimized while still allowing individuals in the industry to share their personal (i.e. non-company) views. Complete anonymity was assured for all respondents.

The survey generated participation by individuals and companies from around the world who provided data concerning an actual drug shortage, a near miss, or an effective shortage prevention program.'/>"/>

SOURCE ISPE
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. HemaQuest Pharmaceuticals Completes Patient Enrollment in Phase 2b Clinical Study of HQK-1001 in Patients with Sickle Cell Disease
2. Study Shows Medical Devices Complicate Complex Conditions in Kids
3. RXi Pharmaceuticals Announces Positive Results in its First Double Blind Study in Healthy Volunteers with RXI-109
4. CSL Behring Doses First Patient in Part 3 of Global Phase I/III Pivotal Study of rVIII-SingleChain (Recombinant Single-Chain Factor VIII) for Treatment of Hemophilia A
5. Boston Scientific Announces Collaboration with Pelvic Floor Disorders Network to Study Treatment Strategies for Uterine Prolapse
6. DelMar Pharmaceuticals Presents Additional Clinical Data from Ongoing Brain Cancer Study at ASCO
7. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
8. Amgen Presents Positive Results From Talimogene Laherparepvec Phase 3 Study In Patients With Metastatic Melanoma
9. Survey of Participants from Landmark GRACE Trial Provides Patients Perspectives from an HIV Clinical Study
10. Novan Announces Promising Results of SB204 Clinical Study
11. Antibiotic Resistance 2013: A Global Market Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... July 24, 2014  In any given hospital in ... patients has at least one hospital-acquired infection, according to ... many of these infections prove fatal. And as increased ... number of patient deaths per year, infection control efforts ... Consequently, a stronger emphasis is being placed ...
(Date:7/24/2014)... , July 24, 2014 /PRNewswire-iReach/ -- Delivery of ... order is placed. Photo - ... professional and in-depth market survey on Global and ... the basic information of Hemodialysis Machine including its ... explores global and China,s top manufacturers of Hemodialysis ...
(Date:7/24/2014)... -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR ) today ... 2014. Three Months Ended 06/30/14Three Months Ended 06/30/13 ,  Percentage ... 51% Non-GAAP Net Sales , $278.8 Million , $196.1 ... , $1.12 , 37% Non-GAAP Diluted ... 37%  Six Months Ended 06/30/14Six Months Ended 06/30/13 , ...
Breaking Medicine Technology:Employees, Equipment and the Environment: Top Infection Prevention Focuses in Hospitals 2Employees, Equipment and the Environment: Top Infection Prevention Focuses in Hospitals 3Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 2Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 3Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 4Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 5Questcor Reports Record Second Quarter Financial Results 2Questcor Reports Record Second Quarter Financial Results 3Questcor Reports Record Second Quarter Financial Results 4Questcor Reports Record Second Quarter Financial Results 5Questcor Reports Record Second Quarter Financial Results 6Questcor Reports Record Second Quarter Financial Results 7Questcor Reports Record Second Quarter Financial Results 8Questcor Reports Record Second Quarter Financial Results 9Questcor Reports Record Second Quarter Financial Results 10Questcor Reports Record Second Quarter Financial Results 11Questcor Reports Record Second Quarter Financial Results 12Questcor Reports Record Second Quarter Financial Results 13Questcor Reports Record Second Quarter Financial Results 14Questcor Reports Record Second Quarter Financial Results 15Questcor Reports Record Second Quarter Financial Results 16Questcor Reports Record Second Quarter Financial Results 17Questcor Reports Record Second Quarter Financial Results 18Questcor Reports Record Second Quarter Financial Results 19Questcor Reports Record Second Quarter Financial Results 20Questcor Reports Record Second Quarter Financial Results 21Questcor Reports Record Second Quarter Financial Results 22Questcor Reports Record Second Quarter Financial Results 23Questcor Reports Record Second Quarter Financial Results 24Questcor Reports Record Second Quarter Financial Results 25Questcor Reports Record Second Quarter Financial Results 26Questcor Reports Record Second Quarter Financial Results 27Questcor Reports Record Second Quarter Financial Results 28
... PharmAthene, Inc. (NYSE Amex: ... biological and chemical threats, announced today that the Company,s ... the position of President and Chief Executive Officer, effective ... Chief Executive Officer in May 2010, and prior thereto ...
... Inc., today reported positive clinical trial results on ... inhalation), an antibiotic that is entering Phase III ...  The results demonstrate significant clinical benefit and complete ... of lung infections due to the bacterium, ...
Cached Medicine Technology:PharmAthene Appoints Eric I. Richman President and Chief Executive Officer 2PharmAthene Appoints Eric I. Richman President and Chief Executive Officer 3ARIKACE™ Demonstrates Sustained Benefit in Multiple Studies and Over Multiple Cycles of Treatment of Pseudomonas Lung Infections in Cystic Fibrosis Patients 2ARIKACE™ Demonstrates Sustained Benefit in Multiple Studies and Over Multiple Cycles of Treatment of Pseudomonas Lung Infections in Cystic Fibrosis Patients 3ARIKACE™ Demonstrates Sustained Benefit in Multiple Studies and Over Multiple Cycles of Treatment of Pseudomonas Lung Infections in Cystic Fibrosis Patients 4ARIKACE™ Demonstrates Sustained Benefit in Multiple Studies and Over Multiple Cycles of Treatment of Pseudomonas Lung Infections in Cystic Fibrosis Patients 5
(Date:7/24/2014)... CA (PRWEB) July 24, 2014 Just ... seriously, they must consider their own financial and marketing ... and weak marketing campaigns to the next level by ... Cloud Call Center, IVR, Voice Broadcast, Call Tracking and ... a 98% open rate, text messages are quickly become ...
(Date:7/24/2014)... Executives (ASAE) announced its 2014 Power of A Award ... of Anesthesiologists (ASA). , The ASA Global Humanitarian ... Award, one of the top honors from ASAE. GHO ... world through education on the global anesthesia crisis and ... ASA was also honored with a Power of A ...
(Date:7/24/2014)... (DM) appears to increase the risk for head and neck ... people with DM, but the risk of HNC in patients ... neck cancer is the sixth most common type of cancer. ... for an estimated 650,000 new cancer cases and 350,000 cancer ... Health Insurance Research Database to examine the risk of HNC ...
(Date:7/24/2014)... Primary care treatment of overweight and obese preschoolers ... compared to when only the child is targeted, according ... and conducted at the University at Buffalo and Women ... study were overweight or obese and had one parent ... or obese, according to body mass index (BMI) measurements, ...
(Date:7/24/2014)... Drinking caffeine may worsen the hot flashes and night ... go through menopause, new survey data suggests. "While ... caffeine intake may be useful for those postmenopausal women ... researcher Dr. Stephanie Faubion, director of the Women,s Health ... But caffeine -- a stimulant found in coffee and ...
Breaking Medicine News(10 mins):Health News:Pump Up Your Gym’s Marketing Muscles with Mobile Marketing: CallFire's Health & Fitness Webinar Week – July 28th to August 1st 2Health News:Pump Up Your Gym’s Marketing Muscles with Mobile Marketing: CallFire's Health & Fitness Webinar Week – July 28th to August 1st 3Health News:Overweight and obese preschoolers lose more weight when parent is also treated 2Health News:Overweight and obese preschoolers lose more weight when parent is also treated 3Health News:Is Coffee Aggravating Your Hot Flashes? 2
... Systems, a premier,provider of integrated professional and technical ... announced today that the Texas,Organization of Rural and ... Health Systems, Inc. endorsed vendor status.,Prior to endorsing ... certain the vendor is qualified to serve its ...
... Leadership authority is,critical for market research high ... leader to help optimize the market research group. ... market research,groups -- where top companies employ a ... and activities across Market,Research divisions, units and geographies., ...
... Passing ABC Plan; Urges Senate to,Act Quickly, ... today praised the House of Representatives for taking ... to Basic Care (PA ABC) plan,and he urged ... PA ABC would provide access to health care ...
... Also Announces Internal Controls and Procedures Improvements, Corporate, ... MCLEAN, Va., March 18 Sunrise Senior Living,Inc. ... informed the New York Stock,Exchange ("NYSE") that the Company ... deadline for filing its 2006 Form 10-K. The Company ...
... beneficial effects on human health, have been used for ... disorders. However, the ways in which probiotic bacteria elicit ... the action mechanisms could be the ability to induce ... At present there is only a limited amount of ...
... The Gram negative bacterium H pylori is involved in ... gastric carcinoma. Adhesion of the bacteria to the gastric ... , It is therefore important to know factors that ... MUC1, a mucin with a highly variable repetitive region ...
Cached Medicine News:Health News:Texas Organization of Rural and Community Hospitals (TORCH) Awards Phoenix Health Systems Endorsed Vendor Status 2Health News:Create Strong Leadership to Add Value to Market Research Function 2Health News:Governor Rendell Says Pennsylvania is One Step Closer to Providing Access to Health Care for Pennsylvania's Uninsured 2Health News:Governor Rendell Says Pennsylvania is One Step Closer to Providing Access to Health Care for Pennsylvania's Uninsured 3Health News:Sunrise Misses NYSE Deadline for Filing 2006 Form 10-K 2Health News:Sunrise Misses NYSE Deadline for Filing 2006 Form 10-K 3Health News:Sunrise Misses NYSE Deadline for Filing 2006 Form 10-K 4Health News:Sunrise Misses NYSE Deadline for Filing 2006 Form 10-K 5Health News:Sunrise Misses NYSE Deadline for Filing 2006 Form 10-K 6Health News:Sunrise Misses NYSE Deadline for Filing 2006 Form 10-K 7Health News:Sunrise Misses NYSE Deadline for Filing 2006 Form 10-K 8Health News:Sunrise Misses NYSE Deadline for Filing 2006 Form 10-K 9Health News:Do bacterial combinations result in enhanced cytokine production? No! 2
Anis tying forcep is extra delicate with smooth jaws, curved. For 9-0 to 11-0 sutures....
Curved shafts and tips with tying surfaces. Wide serrated handle with dull finish. Overall length 4.3 inches....
Straight heavy shafts with 7 mm tying surface. Wide serrated handle, polished finish. Overall length 4.2 inches....
Straight shafts with 6 mm tying platform. Serrated handle with polished finish. Most popular size or model. Overall length 4 inches....
Medicine Products: